1. Home
  2. SFL vs OGN Comparison

SFL vs OGN Comparison

Compare SFL & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SFL Corporation Ltd

SFL

SFL Corporation Ltd

HOLD

Current Price

$10.45

Market Cap

1.5B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.49

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFL
OGN
Founded
2003
1923
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
SFL
OGN
Price
$10.45
$13.49
Analyst Decision
Strong Buy
Hold
Analyst Count
1
5
Target Price
$12.00
$11.40
AVG Volume (30 Days)
1.4M
2.4M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
7.05%
0.60%
EPS Growth
N/A
N/A
EPS
N/A
0.55
Revenue
N/A
$6,216,000,000.00
Revenue This Year
N/A
$0.45
Revenue Next Year
$13.07
$1.67
P/E Ratio
N/A
$24.49
Revenue Growth
N/A
N/A
52 Week Low
$6.73
$5.69
52 Week High
$12.94
$13.49

Technical Indicators

Market Signals
Indicator
SFL
OGN
Relative Strength Index (RSI) 35.21 71.58
Support Level $9.83 $10.05
Resistance Level $11.24 N/A
Average True Range (ATR) 0.33 0.05
MACD -0.05 -0.08
Stochastic Oscillator 15.11 95.83

Price Performance

Historical Comparison
SFL
OGN

About SFL SFL Corporation Ltd

SFL Corp Ltd is an international ship-owning and chartering company. The company is engaged in transporting crude oil and oil products, dry bulk and containerized cargoes, freight of rolling cargo, and offshore drilling and related activities. The company operates as a single reportable segment, generating revenue from long-term, fixed-rate charters. Its Additional revenue sources include sales-type lease interest income, voyage charter and pool revenues, and drilling contract revenues.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: